Scientists working with Turkey’s coronavirus platform have proven through trials on animals that the Ribavirin molecule is effective in virus treatment, said the country’s industry and technology minister on Monday.
“FOUR VACCINE CANDIDATES HAVE BEEN SUCCESSFULLY COMPLETED ON ANIMALS”
An application was made to the Turkish Medicines and Medical Devices Agency to conduct a Phase 3 clinical study on this molecule, Mustafa Varank told the Turkish parliament in his speech on the ministry’s budget plans for next year.
“Our scientists also proved with all pre-clinical experimental results that the nature-identical Griffithsin molecule has an anti-infection effect,” he noted.
He added that trials of a total of four vaccine candidates have been successfully completed on animals, and that efforts are underway to move to the clinical trial stage soon.
A local synthesis of the drug Favipiravir, used in coronavirus treatment, has been also developed through university-industry cooperation, he added.